Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Maternal thyroid hormone is required for parvalbumin neurone development in the anterior hypothalamic area.

Harder L, Dudazy-Gralla S, Müller-Fielitz H, Hjerling Leffler J, Vennström B, Heuer H, Mittag J.

J Neuroendocrinol. 2018 Mar;30(3):e12573. doi: 10.1111/jne.12573.

PMID:
29377458
2.

The LepR-mediated leptin transport across brain barriers controls food reward.

Di Spiezio A, Sandin ES, Dore R, Müller-Fielitz H, Storck SE, Bernau M, Mier W, Oster H, Jöhren O, Pietrzik CU, Lehnert H, Schwaninger M.

Mol Metab. 2018 Feb;8:13-22. doi: 10.1016/j.molmet.2017.12.001. Epub 2017 Dec 7.

3.

Obesity-stimulated aldosterone release is not related to an S1P-dependent mechanism.

Werth S, Müller-Fielitz H, Raasch W.

J Endocrinol. 2017 Dec;235(3):251-265. doi: 10.1530/JOE-16-0550. Epub 2017 Oct 2.

PMID:
28970286
4.

Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis.

Müller-Fielitz H, Stahr M, Bernau M, Richter M, Abele S, Krajka V, Benzin A, Wenzel J, Kalies K, Mittag J, Heuer H, Offermanns S, Schwaninger M.

Nat Commun. 2017 Sep 7;8(1):484. doi: 10.1038/s41467-017-00604-6.

5.

Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism.

Mildner M, Müller-Fielitz H, Stölting I, Jöhren O, Steckelings M, Raasch W.

Naunyn Schmiedebergs Arch Pharmacol. 2017 May;390(5):505-518. doi: 10.1007/s00210-017-1346-7. Epub 2017 Jan 31.

PMID:
28144709
6.

Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability.

Schade D, Kotthaus J, Riebling L, Kotthaus J, Müller-Fielitz H, Raasch W, Hoffmann A, Schmidtke M, Clement B.

J Pharm Sci. 2015 Sep;104(9):3208-19. doi: 10.1002/jps.24508. Epub 2015 Jun 2.

PMID:
26037932
7.

Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.

Müller-Fielitz H, Lau M, Geißler C, Werner L, Winkler M, Raasch W.

Br J Pharmacol. 2015 Feb;172(3):857-68. doi: 10.1111/bph.12949. Epub 2014 Nov 24.

8.

The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.

Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Müller-Fielitz H, Pokorná B, Vollbrandt T, Stölting I, Nadrowitz R, Okun JG, Offermanns S, Schwaninger M.

Nat Commun. 2014 May 21;5:3944. doi: 10.1038/ncomms4944.

PMID:
24845831
9.

Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.

Müller-Fielitz H, Hübel N, Mildner M, Vogt FM, Barkhausen J, Raasch W.

Br J Pharmacol. 2014 Feb;171(3):746-60. doi: 10.1111/bph.12510.

10.

Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.

Schade D, Kotthaus J, Riebling L, Kotthaus J, Müller-Fielitz H, Raasch W, Koch O, Seidel N, Schmidtke M, Clement B.

J Med Chem. 2014 Feb 13;57(3):759-69. doi: 10.1021/jm401492x. Epub 2014 Feb 3.

PMID:
24422530
11.

High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice.

Barclay JL, Shostak A, Leliavski A, Tsang AH, Jöhren O, Müller-Fielitz H, Landgraf D, Naujokat N, van der Horst GT, Oster H.

Am J Physiol Endocrinol Metab. 2013 May 15;304(10):E1053-63. doi: 10.1152/ajpendo.00512.2012. Epub 2013 Mar 26.

12.

Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism.

Müller-Fielitz H, Raasch W.

Horm Metab Res. 2013 Feb;45(2):173-80. doi: 10.1055/s-0032-1327679. Epub 2012 Oct 26.

PMID:
23104420
13.

Involvement of doublecortin-expressing cells in the arcuate nucleus in body weight regulation.

Werner L, Müller-Fielitz H, Ritzal M, Werner T, Rossner M, Schwaninger M.

Endocrinology. 2012 Jun;153(6):2655-64. doi: 10.1210/en.2011-1760. Epub 2012 Apr 4.

PMID:
22492306
14.

Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.

Müller-Fielitz H, Lau M, Jöhren O, Stellmacher F, Schwaninger M, Raasch W.

Br J Pharmacol. 2012 Aug;166(8):2417-29. doi: 10.1111/j.1476-5381.2012.01953.x.

15.

Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation.

Müller-Fielitz H, Landolt J, Heidbreder M, Werth S, Vogt FM, Jöhren O, Raasch W.

Endocrinology. 2012 Mar;153(3):1103-15. doi: 10.1210/en.2011-0183. Epub 2012 Jan 17.

PMID:
22253423
16.

Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.

Miesel A, Müller-Fielitz H, Jöhren O, Vogt FM, Raasch W.

Br J Pharmacol. 2012 Apr;165(8):2721-35. doi: 10.1111/j.1476-5381.2011.01726.x.

17.

New prodrugs of the antiprotozoal drug pentamidine.

Kotthaus J, Kotthaus J, Schade D, Schwering U, Hungeling H, Müller-Fielitz H, Raasch W, Clement B.

ChemMedChem. 2011 Dec 9;6(12):2233-42. doi: 10.1002/cmdc.201100422. Epub 2011 Oct 7.

PMID:
21984033
18.

Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure.

Müller-Fielitz H, Markert A, Wittmershaus C, Pahlke F, Jöhren O, Raasch W.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Apr;383(4):373-84. doi: 10.1007/s00210-011-0602-5. Epub 2011 Feb 3.

PMID:
21287150
19.

Overfeeding-induced obesity in spontaneously hypertensive rats: an animal model of the human metabolic syndrome.

Miesel A, Müller H, Thermann M, Heidbreder M, Dominiak P, Raasch W.

Ann Nutr Metab. 2010;56(2):127-42. doi: 10.1159/000278748. Epub 2010 Feb 5.

PMID:
20134158
20.

Stress sensitivity is increased in transgenic rats with low brain angiotensinogen.

Müller H, Kröger J, Jöhren O, Szymczak S, Bader M, Dominiak P, Raasch W.

J Endocrinol. 2010 Jan;204(1):85-92. doi: 10.1677/JOE-09-0363. Epub 2009 Oct 6.

PMID:
19808775

Supplemental Content

Loading ...
Support Center